Innate Pharma
IPHA | NASDAQ
$1.41
+$0.03 (+2.17%)
At close: Nov 16, 2026, 4:00 PM ET
$1.44
+$0.03 (+2.12%)
After-hours:
Nov 16, 2026, 4:19 PM ET
Innate Pharma Statistics
Key statistics explainedMarket Data
$150.85M
$141.38M
0.88
120.75K
93.44M
15.54%
0.22%
NASDAQ
US45781K2042
Price Performance
-1.4%
-37.6%
-37.3%
-19.4%
-22.5%
-42.5%
-72.2%
-1.4%
-22.5%
-23.6%
-18.8%
Valuation
-2.37
40.01
-0.32
0.03
36.02
2.20
-3.26
-2.88
-2.88
-2.52
39.38
-2.78
-2.85
-3.15
-39.8%
-32.7%
-32.7%
Financial Health
€9.26M
€20.2M
€10.89M
€34.71M
0.60
0.60
-0.50
-0.41
-0.45
-2.21
-17.47
-22.54
2
Margins & Profitability
1770.3%
-1309.4%
-5009.7%
-4554.3%
-1250.7%
-1250.7%
0.0%
N/A
Returns
-136.7%
152.6%
-380.7%
-2860.4%
-136.7%
Historical Growth (CAGR)
-59.5%
-38.6%
-0.4%
-26.8%
12.3%
-6.0%
-29.0%
21.9%
-14.5%
Analyst Forecasts
Buy
2
32.0%
155.4%
Nov 5, 2026
-$0.32
-0.6%
$6.99M
10.3%
Fair Value Estimates
N/A
N/A
N/A
N/A
$7.00
396.5%
Cash Flow
€-44.72M
€-44.9M
€-44.9M
-$0.48
-$0.48
-4091.7%
Income Statement
€3.59M
€24.11M
€-47.01M
€-49.55M
€-47.25M
-$0.51
$22.02K
$-289.88K
163
Add to Watchlist
Select watchlists to add or remove IPHA